XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net Loss $ (14,147,216) $ (23,900,157)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 1,068,498
Unrealized loss on marketable securities 19,895
Depreciation and amortization 88,751 67,612
Stock-based compensation - options 5,869,543 17,422,328
Stock-based compensation - common stock 121,323
Stock-based compensation - RSUs 3,563,716 2,507,368
Shares issued in settlement of litigation 21,000
Gain on PPP loan forgiveness (250,000)
Non-cash lease expense 87,033 87,033
Changes in operating assets and liabilities:    
Accounts receivable (40,000) 9,000
Prepaid assets and other current assets 80,135 73,451
Accounts payable 417,674 5,707
Accrued expenses and other current liabilities (20,321) 528,015
Lease liability (87,945) (74,749)
Net cash used in operating activities (4,297,412) (2,184,894)
Cash flows from investing activities:    
Purchase of marketable securities (9,933,562)
Purchases of equipment (222,642)
Net cash used in investing activities (10,156,204)
Cash flows from financing activities:    
Proceeds from PPP Loan 250,000
Net cash provided by financing activities 250,000
Net decrease in cash and cash equivalents (14,453,616) (1,934,894)
Cash and cash equivalents - beginning of period 21,026,727 3,064,610
Cash and cash equivalents - end of period 6,573,111 1,129,716
Non-cash investing and financing activities:    
Shares issued in exchange for notes payable and accrued interest 317,376
Bifurcated embedded conversion options and warrants recorded as derivative liability and debt discount 166,404
Accrued DIP expenses exchanged for convertible notes $ 698,901